Yun He

Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8+ T cell cytotoxicity in patients with gastric cancer

Jing Jia, Shuixiang He, Junli Xu, 2021, BMC immunology.

Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy.

J. Wong, N. Zhang, Chuan-ming Xie, 2011, Bioorganic & medicinal chemistry letters.

An anti-CTLA-4 heavy chain–only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile

F. Grosveld, D. Drabek, Yiping Rong, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Immunomagnetic Purging of T8 Cells from Peripheral Blood and Bone Marrow: A Preclinical Study for Allogeneic Bone Marrow Transplantation

Y. Gazitt, S. Gross, Yun He, 1992 .

A Δ42PD1 fusion-expressing DNA vaccine elicits enhanced adaptive immune response to HIV-1: the key role of TLR4

B. Ju, X. Tang, Lin Cheng, 2022, Virology Journal.

Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response.

J. Wong, Tai-guang Jin, N. Zhang, 2012, Journal of medicinal chemistry.